Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease

por El-Lebedy, Dalia, Raslan, Hala M., Mohammed, Asmaa M.
Publicado 2016

Erratum to: Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease

por El-Lebedy, Dalia, Raslan, Hala M., Mohammed, Asmaa M.
Publicado 2016

CD33(+) HLA-DR(–) Myeloid-Derived Suppressor Cells Are Increased in Frequency in the Peripheral Blood of Type1 Diabetes Patients with Predominance of CD14(+) Subset

por Hassan, Mirhane, Raslan, Hala M., Eldin, Hesham Gamal, Mahmoud, Eman, Elwajed, Hanaa Alm-elhuda Abd
Publicado 2018

Current and novel modalities for management of chronic hepatitis B infection

por Salama, Iman Ibrahim, Sami, Samia M, Salama, Somaia I, Abdel-Latif, Ghada A, Shaaban, Fatma A, Fouad, Walaa A, Abdelmohsen, Aida M, Raslan, Hala M
Publicado 2023

Endothelial nitric oxide synthase gene (T786C and G894T) polymorphisms in Egyptian patients with type 2 diabetes

por Moguib, Omneya, Raslan, Hala M., Abdel Rasheed, Inas, Effat, Laila, Mohamed, Nadia, El Serougy, Safaa, Hussein, Ghada, Tawfeek, Salwa, AbdelRahman, Amany H., Omar, Khalda
Publicado 2017

Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection

por Salama, Iman Ibrahim, Raslan, Hala M, Abdel-Latif, Ghada A, Salama, Somaia I, Sami, Samia M, Shaaban, Fatma A, Abdelmohsen, Aida M, Fouad, Walaa A
Publicado 2022

Risk Factors Associated with Mild Cognitive Impairment among Apparently Healthy People and the Role of MicroRNAs

por Salama, Iman I., Salama, Somaia I., Elmosalami, Dalia M., Saleh, Rehan M., Rasmy, Hanaa, Ibrahim, Mona Hamed, Kamel, Solaf Ahmed, Ganem, Mona M. F., Raslan, Hala M.
Publicado 2019

Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus

por Salama, Iman I., Sami, Samia M., Abdellatif, Ghada A., Mohsen, Amira, Rasmy, Hanaa, Kamel, Solaf Ahmed, Ibrahim, Mona Hamed, Mostafa, Mona, Fouad, Walaa A., Raslan, Hala M.
Publicado 2020

Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension

por Dimitry, Mark O., Soliman, Youssef M. A., ElKorashy, Reem I., Raslan, Hala M., Kamel, Solaf A., Hassan, Eman M., Ahmed, Fatma Elzahraa, Yousef, Rasha N., Awadallah, Eman A.
Publicado 2023

Correction: Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus

por Salama, Iman I., Sami, Samia M., Abdellatif, Ghada A., Mohsen, Amira, Rasmy, Hanaa, Kamel, Solaf Ahmed, Ibrahim, Mona Hamed, Ganem, Mona M.F., Fouad, Walaa A., Raslan, Hala M.
Publicado 2020

Impact of lifestyle modification on glycemic control and cognitive function among Type II diabetes mellitus patients

por Salama, Iman I, Sami, Samia M, Salama, Somaia I, Abdel-Latif, Ghada A, Aboulghate, Ahmed, Raslan, Hala M, Mohsen, Amira, Rasmy, Hanaa, Ibrahim, Mona Hamed, Ganem, Mona MF, Abdelmohsen, Aida M, El-Etreby, Lobna A, Ibrahim, Nihad A, Fouad, Walaa A, El-Deeb, Sherif E
Publicado 2023